Federal Register / Vol. 69, No. 217 / Wednesday, November 10, 2004 / Notices 65229

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), Title 

Council of America (‘‘TCA’’) has filed 

written notifications simultaneously 

with the Attorney General and the 

Federal Trade Commission disclosing 

(1) the name and principal place of 

business of the standards development 

organization and (2) the nature and 

scope of its standards development 

activities. The notifications were filed 

for the purpose of invoking the Act’s 

provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Pursuant to section 6(b) of the Act, the 

name and principal place of business of 

the standards development organization 

is: Title Council of America, Anderson, 

SC. The nature and scope of TCA’s 

standards development activities are: 

Standard specifications for the 

installation of ceramic tile, for ceramic 

title installation materials, and for 

ceramic tile including tile, porcelain 

tile, glass tile, and special purpose tile.

Dorothy B. Fountain, 

Deputy Director of Operations, Antitrust 

Division.

[FR Doc. 04–25076 Filed 11–9–04; 8:45 am] 

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Wild Bird Feeding 

Industry 

Notice is hereby given that, on 

September 23, 2004, pursuant to section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), Wild 

Bird Feeding Industry (‘‘WBFI’’) has 

filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing (1) the name and 

principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to section 6(b) of the Act, the 

name and principal place of business of 

the standards development organization 

is: Wild Bird Feeding Industry, Sioux 

Falls, SD. The nature and scope of 

WBFI’s standards development 

activities are: Investigating and 

developing standards of identity and 

quality for products sold for wild birds. 

These products include feeders, houses, 

baths and accessories, and seed and 

other food.

Dorothy B. Fountain, 

Deputy Director of Operations, Antitrust 

Division.

[FR Doc. 04–25084 Filed 11–9–04; 8:45 am] 

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated May 21, 2004, and 

published in the Federal Register on 

June 3, 2004, (69 FR 31411), American 

Radiolabeled Chemicals, Inc., 101 Arc 

Drive, St. Louis, Missouri 63146, made 

application by renewal to the Drug 

Enforcement Administration (DEA) for 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed below:

Drug Schedule 

Gamma hydroxybutyric acid 

(2010).

I 

Dimethyltryptamine (7435) ......... I 

Dihydromorphine (9145) ............. I 

Cocaine (9041) ........................... II 

Codeine (9050) ........................... II 

Hydromorphone (9150) .............. II 

Benzoylecgonine (9180) ............. II 

Ecgonine (9180) ......................... II 

Meperidine (9230) ...................... II 

Metazocine (9240) ...................... II 

Morphine (9300) ......................... II 

Oxymorphone (9652) .................. II 

The company plans to manufacture in 

bulk, small quantities of the listed 

controlled substances as radiolabeled 

compounds. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

American Radiolabeled Chemicals, Inc. 

to manufacture the listed basic classes 

of controlled substances is consistent 

with the public interest at this time. 

DEA has investigated American 

Radiolabeled Chemicals, Inc. to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed.

Dated: November 1, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–25103 Filed 11–9–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to 21 CFR 1301.33(a), Title 

21 of the Code of Federal Regulations 

(CFR), this is notice that on July 28, 

2004, Guilford Pharmaceuticals, Inc., 

6611 Tributary Street, Baltimore, 

Maryland 21224, made application by 

renewal to the Drug Enforcement 

Administration (DEA) for registration as 

a bulk manufacturer of Cocaine (9041), 

a basic class of controlled substance in 

Schedule II. 

The company plans to manufacture a 

cocaine derivative to be used as an 

intermediate for the production of 

Dopascan Injection. Cocaine derivatives 

are a Schedule II controlled substance in 

the cocaine basic class. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such a substance 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such comments or objections 

may be addressed, in quintuplicate, to 

the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, United 

States Department of Justice, 

Washington, DC 20537, Attention: DEA 

Federal Register Representative Office 

of Liaison and Policy (ODLR) and must 

be filed no later than January 10, 2005.

Dated: November 1, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–25104 Filed 11–9–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to Section 1301.33(a) of Title 

21 of the Code of Federal Regulations 

(CFR), this is notice that on August 16,